Podoviridae bacteriophage for the biocontrol of Pseudomonas aeruginosa in rainwater by Reyneke, B et al.
1 
 
Podoviridae bacteriophage for the biocontrol of Pseudomonas aeruginosa in rainwater 1 
Brandon Reynekea, Sehaam Khanb, Pilar Fernández-Ibáñezc and Wesaal Khana* 2 
 3 
a Department of Microbiology, Faculty of Science, Stellenbosch University, Private Bag X1, 4 
Stellenbosch, 7602, South Africa. 5 
b Faculty of Health Sciences, University of Johannesburg, PO Box 17011, Doornfontein, 2028, 6 
South Africa. 7 
c Nanotechnology and Integrated BioEngineering Centre, School of Engineering, University of 8 
Ulster, Newtownabbey, Northern Ireland, United Kingdom. 9 
 10 
Short title: Bacteriophage biocontrol of Pseudomonas aeruginosa  11 
 12 
 13 
*Corresponding Author: Wesaal Khan; Phone: +27218085804; Email: wesaal@sun.ac.za  14 
 15 
Appendix A: Electronic supplementary information available - Legionella spp. growth conditions 16 
and modified protocol for host range determination. List of target and non-target bacterial species 17 
(host range determination). Sequencing results of the Podo-Hypo-F/R (Podoviridae) and Myo-18 
Hypo-F/R (Myoviridae) primer sets. qPCR performance characteristics. Summary of cell counts, 19 
gene copies and log reductions recorded for the pre-treatment/SODIS-CPC trials. Characterisation 20 
results for the isolated bacteriophages (i.e. temperature and pH sensitivity) and results obtained for 21 





Bacteriophages targeting Pseudomonas spp. were isolated and characterised for the biocontrol 25 
pre-treatment of harvested rainwater. Bacteriophages PAW33 (isolated using P. aeruginosa) and 26 
PFW25 (isolated using P. fluorescens) were characterised as members of the Podoviridae and 27 
Myoviridae families, respectively. Bacteriophage PAW33 displayed a broad host range against 28 
P. aeruginosa strains, while PFW25 was more effective in infecting K. pneumoniae than 29 
P. fluorescens (original target organism). PAW33 was subsequently applied in small-scale 30 
bacteriophage pre-treatment trials (8 h and 24 h), to evaluate its efficacy in restricting the 31 
proliferation of an environmental P. aeruginosa S1 68 strain. Following the completion of the 32 
bacteriophage pre-treatment trial, the respective samples (bacteriophage pre-treated samples and 33 
non-pre-treated control samples) were subjected to treatment in small-scale (vol?) solar 34 
disinfection compound parabolic collector (SODIS-CPC) systems for 4 h under natural sunlight. For 35 
the 8 h trial followed by SODIS-CPC, similar total log reductions in colony forming units (CFU) and 36 
gene copies (GC)/mL were obtained for the bacteriophage pre-treated [3.68 log (CFU) and 2.34 37 
log (GC)] and non-pre-treated [3.74 log (CFU) and 2.33 log(GC)] samples. In contrast, culture-38 
based analysis of the 24 h trial samples (followed by SODIS-CPC) indicated that a higher overall 39 
log reduction was recorded for the pre-treated sample (4.61 log) in comparison to the non-pre-40 
treated sample (3.91 log), while comparable log reductions were obtained using viability-qPCR 41 
(2.32 log and 2.26 log, respectively). Gene expression analysis then indicated that PAW33 pre-42 
treatment for 24 h influenced the ability of P. aeruginosa S1 68 to initiate stress response 43 
mechanisms during the 4 h SODIS-CPC treatment (downregulation of the recA and lexA genes) 44 
and resulted in the downregulation of the phzM gene (virulence factor responsible for pyocyanin 45 
production). Bacteriophage PFW33 thus displays promise as a biocontrol pre-treatment strategy of 46 
roof-harvested rainwater as it restricts the proliferation of P. aeruginosa and may increase the 47 
treatment efficiency of primary disinfection methods. 48 
Key words: Podoviridae; Pseudomonas spp.; Solar Disinfection; Virulence; Stress Response  49 
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1. Introduction 50 
Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen and is primarily associated 51 
with nosocomial infections where it may cause pneumonia, urinary tract and skin infections 52 
(Driscoll et al., 2007). However, the ubiquitous distribution of Pseudomonas spp. in the 53 
environment significantly increases the health risk associated with this organism and John et al. 54 
(2017) recently reported on an outbreak of community-acquired P. aeruginosa pneumonia in Cape 55 
Town, South Africa. The authors noted that while no cases of community-acquired P. aeruginosa 56 
were reported at a local government hospital over a 10-year period (2007 to 2016); over a period of 57 
three months (March to May 2017), 9 cases were reported. This outbreak coincided with a severe 58 
drought in Cape Town (2017 to 2018), where stringent water restrictions were implemented and 59 
residents were increasingly using alternative water sources (e.g. rainwater and grey water). It was 60 
hypothesised that the use of these alternative water sources may have led to the exposure of the 61 
community members to P. aeruginosa. 62 
Although various treatment methods have been implemented to reduce the levels or remove 63 
pathogens and opportunistic pathogens from environmental water reservoirs, many 64 
microorganisms employ survival strategies and are capable of persisting. Certain strains of P. 65 
aeruginosa have been shown to survive conventional disinfection strategies including sub-optimal 66 
chlorination (Shrivastava et al., 2004), ultra-violet (UV) radiation (Strauss et al., 2016; 2018) and 67 
heat treatment (Strauss et al., 2016; Clements et al., 2019). Using viability-qPCR, Strauss et al. 68 
(2016) reported on the detection of Pseudomonas spp. in rainwater samples treated at solar 69 
pasteurization temperatures > 90 °C and in water samples treated by solar disinfection (SODIS; 70 
UV radiation and solar mild-heat) for 8 hours. Similarly, using culture-based methods, Clements et 71 
al. (2019) isolated Pseudomonas spp. from rainwater samples pasteurized at temperatures > 72 
70 °C, with certain isolates identified as P. aeruginosa using species-specific primers. 73 
Pseudomonas aeruginosa has also readily been detected in grey water (Winward et al., 2008; 74 
Maimon et al., 2014), with Gross et al. (2007) and Gilboa and Friedler (2008) reporting on the 75 
detection of viable P. aeruginosa in grey water samples treated in a vertical flow bioreactor and a 76 
rotating biological contractor followed by UV disinfection, respectively. The survival of 77 
4 
 
Pseudomonas spp. during water treatment has subsequently been attributed to the initiation of 78 
stress response mechanisms, including heat-shock proteins and deoxyribonucleic acid (DNA) 79 
repair mechanisms, the ability of the organisms to form biofilms and survive intracellularly within 80 
protozoa (Strauss et al., 2016; Clements et al., 2019). As bacteria are able to undergo an adaptive 81 
response and build-up resistance to conventional disinfection treatments (Wesche et al., 2009), 82 
alternative treatment strategies targeting pathogenic species directly are required. 83 
Bacteriophage therapy or bacteriophage biocontrol has gained increased interest in recent years, 84 
due to the specificity with which pathogens may be targeted. Bacteriophages are bacterial viruses, 85 
which are ubiquitously distributed in the environment and may interact with bacteria by either 86 
causing lysis of the host cell (lytic phages) or integrating their phage genome into the host cell 87 
(temperate phages) (Wu et al., 2017). Numerous studies have subsequently reported on the 88 
potential of bacteriophage biocontrol to target food-borne pathogens (food safety) (Greer, 2005); 89 
biofilm formation on medical devices or treat infectious diseases (human and veterinary medicine) 90 
(Clark and March, 2006); to reduce economic losses in agriculture (targeting plant pathogens) and 91 
aquaculture (targeting fish pathogens) (Vinod et al., 2006; Frampton et al., 2012); or in 92 
bioremediation strategies for the selective removal of bacteria from water (Whitey et al., 2005). 93 
While investigating the use of bacteriophages for the biocontrol of Salmonella spp. in wastewater, 94 
Turki et al. (2012) showed that the isolated bacteriophages were able to reduce the proliferation of 95 
the target pathogen (reduction in sample optical density) over time in co-culture experiments. 96 
Additionally, using DNA fingerprinting analysis [PCR based amplification of enterobacterial 97 
repetitive intergenic consensus (ERIC) sequences], the authors reported on the decreased 98 
detection of the enterobacterial community and Salmonella spp. in the treated wastewater over 99 
time (0 h to 8 h). Similarly, Goldman et al. (2009) reported that bacteriophage treatment could 100 
reduce membrane fouling caused by the opportunistic pathogens Acinetobacter johnsonii, Bacillus 101 
subtilis and P. aeruginosa, by 40 to 60%. An added benefit of using bacteriophages to target 102 
persisting pathogens is the relative ease with which this treatment can be combined with existing 103 
disinfection methods. For example, Zhang et al. (2013) applied a mixture of P. aeruginosa 104 
bacteriophages to selectively remove this organism from water passing through granular activated 105 
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carbon and anthracite biofilters. Results indicated that the bacteriophage treatment was able to 106 
reduce P. aeruginosa concentration by 55 to 75% in the two biofilter systems, with minimal impact 107 
on the beneficial microorganisms, and thereby contribute to an improvement in effluent water 108 
quality. 109 
Additionally, solar radiation can be used to reduce viable pathogenic organisms in water by the 110 
exposure of water to natural or concentrated sunlight. When the polluted water is placed in plastic 111 
transparent containers to direct sunlight for 6 h, it is known as SODIS. It has been widely 112 
investigated as disinfection method that helps reducing the presence of pathogens in water and the 113 
incidence of diarrheal diseases. One of the main disadvantages of SODIS is the low efficiency of 114 
the treatment for resistant pathogens  [McGuigan et al., 2012]. To enhance the efficiency of solar 115 
disinfection, the use of compound parabolic collectors (CPC) has been investigated for specific 116 
pathogens [Ubomba-Jaswa et al., 2010]. The authors that CPC solar mirrors are a good solution to 117 
disinfect 25 L of water containing E. coli (6-log and 3-log reduction in 5 h on sunny days, and 118 
cloudy conditions, respectively). For resistant microorganisms (pseudomonas, cryptosporidium, 119 
MS2 bacteriophage, etc.) more research must be done to improve their efficient removal. 120 
Legionella, Pseudomonas and Klebsiella spp. in solar disinfection systems, including SOPAS, are 121 
not completely effective as these bacteria have repair mechanisms and capacity to resist this 122 
treatment [Dobrowsky et al., 2016]. Therefore, additional treatment technologies might be explored 123 
to effectively eliminate these organisms from water sources. 124 
The primary aim of the current study was thus to isolate and characterise bacteriophages targeting 125 
Pseudomonas spp. and apply the best performing bacteriophage as a biocontrol pre-treatment (8 126 
and 24 h) of roof-harvested rainwater. Following the completion of the bacteriophage pre-treatment 127 
trial, the respective samples (bacteriophage pre-treated samples and non-pre-treated control 128 
samples) were subjected to treatment in small-scale SODIS-CPC systems. Culture- and molecular-129 
based (viability-qPCR) analysis were used to quantify P. aeruginosa S1 68 and bacteriophage 130 
PAW33 during the pre-treatment and SODIS trials, while gene expression assays were used to 131 
monitor the expression of P. aeruginosa S1 68 stress response and virulence genes. 132 
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2. Materials and Methods 133 
2.1 Bacterial Strains and Growth Conditions 134 
Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, P. fluorescens ATCC 13525 and 135 
P. protegens ATCC 17386 reference strains were obtained from Microbiologics® (St Cloud, 136 
Minnesota, USA) and were used for the isolation, propagation and characterisation of the 137 
bacteriophages. The bacterial strains (target and non-target bacterial species) utilised for the host 138 
range determination of the isolated bacteriophages are indicated in Appendix A, Table S1. All 139 
strains were cultured at 30 °C in tryptic soy broth (TSB; Biolab, Merck, Wadeville, South Africa) or 140 
on tryptic soy agar (TSA; Biolab, Merck), with the exception of Legionella spp. (see Appendix A for 141 
Legionella spp. growth conditions). For the double-layer plaque assays (double-layer overlays), the 142 
TSA medium contained 1.2% (w/v) Agar Bacteriological (Biolab, Merck) in the bottom layer and 143 
0.6% agar (w/v) in the soft top layer (Sillankorva et al., 2008). 144 
2.2 Isolation, Purification and Propagation of Bacteriophages 145 
Bacteriophages were isolated by screening various environmental water sources including influent 146 
wastewater collected from the Stellenbosch Wastewater Treatment Plant (GPS co-ordinates: -147 
33.943505, 18.824584), river water from the Plankenburg River (GPS co-ordinates: -33.927761, 148 
18.850544) and roof-harvested rainwater from a rainwater harvesting tank connected to the JC 149 
Smuts building at Stellenbosch University (GPS co-ordinates: -33.930858, 18.865611). Selection 150 
for Pseudomonas spp. bacteriophages was performed as previously described by Sillankorva et al. 151 
(2008), with minor modifications. Briefly, following the centrifugation step (10 000 × g; 10 min; 152 
4 °C), the supernatant from each sample was filtered through a sterile GN-6 Metricel® S-Pack 153 
Membrane Disc Filter (Pall Life Sciences, Michigan, USA) with a pore size of 0.45 μm, to remove 154 
residual host bacteria from the sample (Vinod et al., 2006). The filtered supernatant was tested for 155 
the presence of bacteriophages (Sillankorva et al., 2008), whereaafter five repeated rounds of 156 
plaque purification and re-infection were performed (Stenholm et al., 2008). 157 
The bacteriophages were selected for further studies based on their initial lysis profiles during 158 
bacteriophage purification (number and consistency of plaque formation, plaque clarity and plaque 159 
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size) (Sillankorva et al., 2008). Code identifiers were assigned to the isolated bacteriophages 160 
based on the bacteria from which they were isolated (i.e. PA – P. aeruginosa; PF – P. fluorescens 161 
and PP – P. protegens), the source of the bacteriophage (e.g. W – wastewater; R – river water) 162 
and the plaque number. For example, PAW1 indicates that the bacteriophage was isolated using 163 
P. aeruginosa (PA), from wastewater (W) and was the first plaque isolated (1). 164 
The purified bacteriophages were used to prepare concentrated bacteriophage solutions for use in 165 
subsequent experiments using the small-scale liquid culture method as described by Sambrook 166 
and Russell (2001), with minor modifications. Briefly, following the onset of bacterial cell lysis, the 167 
samples were centrifuged (10 000 × g; 10 min; 4 °C) and filtered through a 0.2 µm Acrodisc® PF 168 
syringe filter (Pall Life Sciences). The filtered supernatants were centrifuged at 25 000 × g for 169 
60 min using an Avanti J-E Centrifuge with a JA 20 fixed angle rotor (Beckman Coulter, California, 170 
USA). Following centrifugation, the supernatant was removed and the obtained pellet was re-171 
suspended in 1 mL SM-buffer [5.8 g/L sodium chloride (NaCl; Saarchem, Durban, South Africa), 172 
2 g/L magnesium sulphate heptahydrate (MgSO4.7H2O; Saarchem), 50 mL 1 M Tris, pH 7.5]. The 173 
plaque forming units (PFU) per mL concentrated sample were determined by serial dilution (10-1 to 174 
10-5) in SM-buffer and double-layer plaque assays. The concentrated bacteriophage samples in 175 
SM-buffer were stored at 4 °C until further use. 176 
2.3 Characterisation of the Isolated Bacteriophages 177 
In order to increase bacteriophage retention on the electron microscopy grids and thereby increase 178 
bacteriophage visualisation during electron microscopy analysis, the hydrophilicity and “stickiness” 179 
of the 200 mesh carbon-coated Formvar grids (Agar Scientific, Essex, United Kingdom) were 180 
increased by using an alcian blue (Electron Microscopy Sciences, Pennsylvania, USA) pre-181 
treatment (1% alcian blue in 1% acetic acid in water) as described by Laue and Bannert (2010). 182 
Concentrated bacteriophage samples with a titre of > 109 PFU/mL were then mixed with 183 
glutaraldehyde (2.5% v/v; Agar Scientific) for 5 min and 25 µL of the glutaraldehyde treated 184 
concentrated bacteriophage sample was loaded onto the alcian blue pre-treated grids and were 185 
allowed to settle for 10 min. Hereafter, the sample was stained with 1% uranyl acetate for 2 min. 186 
Excess stain was removed using filter paper and the grids were allowed to air dry. The grids were 187 
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visualised with a Zeiss MERLIN Field Emission Scanning Electron Microscope (FE-SEM; Zeiss, 188 
Germany) at the Electron Microbeam Unit of the Central Analytical Facility (CAF) at Stellenbosch 189 
University. A Zeiss five-diode Scanning Transmission Electron Detector (Zeiss aSTEMA Detector) 190 
and Zeiss Smart SEM software was used to generate STEM images. Beam conditions during 191 
analysis on the Zeiss MERLIN FE-SEM were 20 kV accelerating voltage, 150 pA probe current, 192 
with a working distance of approximately 3.9 to 4.0 mm. Images were acquired in bright fields 193 
mode with the S1 diode activated. 194 
2.4 Analysis of Bacteriophage Nucleic Acids - Restriction Enzyme Digestion and Molecular 195 
Analysis 196 
To ensure that no potential residual host bacterial DNA was analysed in the subsequent 197 
bacteriophage nucleic acid determination, 500 µL of the concentrated bacteriophage samples was 198 
treated with DNaseI (Thermo Scientific, Lithuania) as outlined in Reyneke et al. (2017). Following 199 
the DNase treatment, bacteriophage nucleic acid was extracted from the concentrated samples 200 
using the NucleoSpin® Tissue kit (Macherey-Nagel, Düren, Germany) according to the 201 
manufacturer’s instructions. 202 
The type of nucleic acid was confirmed by treatment with DNaseI (dsDNA; Thermo Scientific), S1 203 
nuclease (ssDNA; Thermo Scientific) and RNase [ribonucleic acid (RNA); Fermentas, Thermo 204 
Scientific] (Vinod et al., 2006), while the purified bacteriophage nucleic acids were digested with 205 
either EcoRI (Roche Diagnostics, Risch-Rotkreuz, Switzerland) or ClaI (Fermentas) (Stenholm et 206 
al., 2008). All nuclease and restriction enzyme digestions were performed according to the 207 
manufacturer’s instructions.  208 
In order to confirm the preliminary classification of the isolated bacteriophages, primers targeting 209 
families within the Caudovirales order, namely Podoviridae and Myoviridae, were designed. The 210 
PhiSiGns online bacteriophage genes and primers tool as described by Dwivedi et al. (2012) was 211 
used to identify signature genes within the respective bacteriophage families. The identified gene 212 
sequences were retrieved from the Genbank sequence database of the National Center for 213 
Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/genbank/) and were aligned using 214 
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ClustalX version 2.0.10 (Larkin et al., 2007) and visualised using GeneDoc version 2.7.00 215 
(Nicholas and Nicholas, 1997). Primers targeting the specific gene sequences were designed 216 
based on the sequence alignments and are presented in Table 1 along with the respective PCR 217 
cycling parameters. Each PCR assay was performed in a final volume of 25 µL and consisted of 218 
1X Green GoTaq® Flexi buffer (Promega, Madison, WI, USA), 2.0 mM MgCl₂ (Promega), 0.1 mM 219 
dNTP mix (Thermo Scientific Fisher, Finland), 0.1 μM of the respective forward and reverse PCR 220 
primers (Table 1), 1.5 U GoTaq® Flexi DNA polymerase (Promega) and 5 μL template DNA. 221 
Sterile distilled H₂O was used as a negative control. 222 
All samples (digested nucleic acids and PCR products) were analysed by agarose gel 223 
electrophoresis in 0.8% agarose (SeaKem® LE Agarose; Lonza, Rockland, ME, USA) containing 224 
0.5 µg/mL ethidium bromide, at 50 volts for 180 min (digested nucleic acids) or 80 volts for 80 min 225 
(PCR products) with the use of 1X tris/acetic acid/ethylenediaminetetraacetic acid (EDTA) (TAE) 226 
buffer followed by visualisation on a Vilber Lourmat gel documentation system (Vilber Lourmat, 227 
Collegien, France). The digested samples were compared to undigested bacteriophage nucleic 228 
acid and the GeneRuler 1 kb Plus DNA ladder (Thermo Scientific). The genome size of the isolated 229 
bacteriophages was estimated by compiling the DNA fragment sizes using the standard ladder (Yu 230 
et al., 2013). The obtained PCR products were cleaned and concentrated using the Wizard® SV 231 
Gel and PCR Clean-up System (Promega) and were sent for DNA sequencing to the CAF at 232 
Stellenbosch University. Sequences were examined using FinchTV version 1.4.0 software and 233 
identification completed using the NCBI Basic Local Alignment Search Tool (BLAST) 234 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 235 
2.5 Host Range Determination 236 
The host range of the isolated bacteriophages was determined by spotting 10 µL of the 237 
concentrated bacteriophage stock solutions (106 to 107 PFU/mL) on TSA (with the exception of 238 
Legionella spp.; Appendix A) with 5 mL freshly prepared soft top-agar, which had been inoculated 239 
with 50 to 100 µL of the strain to be tested and incubating the plates at 30 °C for 18 h (Sillankorva 240 
et al., 2008; Stenholm et al., 2008). The host range for each bacteriophage was determined in 241 
triplicate for each bacteriophage-host combination and consisted of screening 20 Pseudomonas 242 
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spp. (target bacterial strains; Appendix A, Table S1) and 57 non-target bacterial strains 243 
representative of 14 genera (Appendix A, Table S1). Reference, environmental and clinical isolates 244 
of both the target and non-target bacterial strains were included in the host range determination 245 
analysis. 246 
2.6 One-step Growth Curve and Bacteriophage Sensitivity to Physical Parameters 247 
Based on the results obtained during the host range determination, K. pneumoniae ATCC 10031 248 
was used as the host for PFW25 during subsequent experimentation, while P. aeruginosa ATCC 249 
27853 was used as the host for PAW33. One-step growth curves were performed to determine the 250 
latency period and burst size of the isolated bacteriophages, as previously described by 251 
Sillankorva et al. (2008), with minor modifications. Briefly, a multiplicity of infection (MOI) of 0.0003 252 
was used and samples were collected every 10 min over a period of 2 h. Following overnight 253 
incubation at 30 °C, the PFU for each time point was recorded and results were reported as the 254 
average number of bacteriophages released per infected host cell. The bacteriophage burst size 255 
(number of bacteriophages released per infected host cell) was computed as the ratio between the 256 
final bacteriophage count and the initial bacteriophage count recorded during the latency period 257 
(Ciacci et al., 2018). 258 
The influence of pH on the isolated bacteriophages’ stability was evaluated by suspending 259 
bacteriophages at ~ 106 PFU/mL in 1 mL SM-buffer aliquots, with a pH range of 4.0 to 10.0 260 
(intervals of 1 unit) (Jamal et al., 2015; Ciacci et al., 2018). The bacteriophage solutions were then 261 
incubated at room temperature for 1 h, whereafter the bacteriophage titre (PFU/mL) in the 262 
solutions were determined using double-layer plaque assays. The effect of temperature on 263 
bacteriophage stability was assessed by incubating 2 mL bacteriophage suspensions (~ 105 264 
PFU/mL in SM-buffer) at 30 °C (control), 40 °C, 50 °C, 60 °C and 70 °C for 2 h. Samples were 265 
collected for bacteriophage titre (PFU/mL) determination at each temperature, using double-layer 266 
plaque assays, at 0, 10, 30, 60 and 120 min.  267 
2.7 Bacterial Challenge Tests 268 
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To determine the activity of the isolated bacteriophages against the respective host bacterial 269 
species (PAW33 – P. aeruginosa ATCC 2785; PFW25 – K. pneumoniae ATCC 10031), bacterial 270 
challenge tests were performed as described by Turki et al. (2012) with minor modifications. 271 
Briefly, 50 mL TSB was inoculated with an overnight culture of the respective host bacterial 272 
species and corresponding bacteriophage to achieve MOI values of 1, 0.1 and 0.01. A non-infected 273 
culture of the respective host bacterial species was included as a negative control. All challenge 274 
tests were performed in triplicate. The flasks were incubated at 30 °C on a rotary shaker (New 275 
Brunswick Scientific, NY, USA) at 120 rpm for 24 h. Samples were collected every 2 h for the first 8 276 
h and every 4 h thereafter to monitor host bacterial growth within the samples by measuring the 277 
optical density at 650 nm with a T60 Visible Spectrophotometer (PG-Instruments Limited, 278 
Leicester, UK).  279 
To determine whether bacteriophage resistant mutants had emerged during the bacterial challenge 280 
tests, 2 mL aliquots were collected after the 24 h incubation and were centrifuged at 10 000 × g for 281 
5 min (SpectrafugeTM 24D Digital Microcentrifuge, Labnet International, Edison, USA). The 282 
bacterial pellet was re-suspended and was used to inoculate 5 mL freshly prepared soft top-agar, 283 
which was poured onto TSA plates. Ten microliters of concentrated bacteriophage stock solutions 284 
(106 to 107 PFU/mL) were spotted onto the surface of the plate and the plates were incubated at 285 
30 °C for 18 h. Following incubation, the plates were examined for plaque formation to determine 286 
whether the respective host bacterial species were still susceptible to the isolated bacteriophages. 287 
The concentration of the respective host bacterial species within the samples, after the 24 h 288 
bacterial challenge tests, was determined by preparing serial dilutions (10-1 to 10-4) and spread-289 
plating 100 µL of the samples onto TSA, incubating at 30 °C for 18 h and then enumerating the 290 
colony forming units (CFU) per mL. Additionally, based on the results obtained for the bacterial 291 
challenge test performed on the P. aeruginosa ATCC 27853 strain, agglutination tests were 292 
performed to screen for lipopolysaccharide (LPS) defective mutants (Le et al., 2014). 293 
2.8 Small-scale Bacteriophage Pre-treatment of Spiked Rainwater and SODIS-CPC Trials 294 
Two small-scale bacteriophage pre-treatment (8 h or 24 h) and SODIS-CPC trials were performed 295 
using bacteriophage PAW33 and the environmental isolate P. aeruginosa S1 68. Roof-harvested 296 
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rainwater was collected from a rainwater tank located on a local farm (GPS coordinates: 297 
33°56'38.5"S 18°46'26.3"E), where after four 1 L rainwater aliquots were autoclaved three times. 298 
An overnight culture of the environmental P. aeruginosa S1 68 strain was spiked into each of the 299 
four 1 L rainwater aliquots to achieve a final concentration of 1.0 × 107 CFU/mL. Two of the 1 L 300 
rainwater aliquots were simultaneously spiked with 500 µL of a concentrated bacteriophage 301 
solution to achieve an MOI of 0.01, with one of the samples incubated for 8 h and the other aliquot 302 
incubated for 24 h at 30 °C at 120 rpm on a rotary shaker (New Brunswick Scientific). The 303 
remaining two 1 L rainwater aliquots served as the no bacteriophage treatment controls and were 304 
spiked with 500 µL sterile SM-buffer and were also incubated for 8 and 24 h at 30 °C at 120 rpm 305 
on a rotary shaker. Ten millilitre aliquots were collected at 0 and 8 h time intervals from the 8 h pre-306 
treatment and corresponding no pre-treatment control samples and at 0, 1, 2, 4, 8, 16 and 24 h 307 
time intervals from the 24 h pre-treatment and corresponding no pre-treatment control samples. 308 
Four SODIS-CPC reactors (described in Waso et al. 2019), with a treatment capacity of 500 mL, 309 
were filled with the 8 h or 24 h pre-treated samples or the 8 h or 24 h no pre-treatment control 310 
samples, respectively, and were exposed to natural sunlight for 4 h. The remaining rainwater from 311 
each sample (± 400 mL) was incubated at room temperature in the dark over the same time period 312 
to serve as the “dark controls” for the SODIS-CPC trial. Samples (10 mL) were collected from each 313 
SODIS-CPC system at 0, 1, 2, 3 and 4 h. The temperature of the collected samples was monitored 314 
with a hand-held mercury thermometer (ALLA France®, Chemillé, France). 315 
 316 
2.8.1 Culture and Viability-qPCR Analysis of Samples 317 
Culture-based analysis [10-fold serial dilutions and spread plating (P. aeruginosa S1 68) or double-318 
layer agar overlays (PAW33) (described in section 2.2 and 2.7)] were used to enumerate the 319 
P. aeruginosa S1 68 CFU/mL and PAW33 PFU/mL. 320 
However, as Pseudomonas spp. may enter a viable but non-culturable state during unfavourable 321 
conditions (such as those experienced during disinfection treatments), viability-qPCR assays were 322 
included to monitor the gene copy numbers of P. aeruginosa S1 68. Briefly, 2 mL of a collected 323 
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sample was centrifuged at 10 000 × g for 10 min. The obtained pellet was re-suspended in 1 mL 324 
saline (0.85% NaCl), whereafter the sample was treated with 6 µM ethidium monoazide bromide 325 
(EMA; Biotium, Hayward, CA, USA) as outlined in Reyneke et al. (2017). Deoxyribonucleic acid 326 
extraction was completed using the Quick-DNATM Fecal/Soil Microbe Miniprep Kit (Zymo Research, 327 
Inqaba Biotech, South Africa) according to the manufacturers’ instructions.  328 
Similarly, in order to ensure that only DNA from intact (infective) PAW33 virions were quantified 329 
during qPCR analysis, 2 mL of a collected sample was treated with 5 U/mL DNase (Thermo 330 
Scientific) as outlined in Reyneke et al. (2017), whereafter the sample was centrifuged at 331 
25 000 × g for 60 min. The obtained pellet was re-suspended in the pre-lyse mixture (Buffer T1, B3 332 
and Proteinase K) of the NucleoSpin® Tissue kit (Macherey-Nagel) and the DNA extraction was 333 
completed as outlined by the manufacturer. 334 
2.8.2 RNA Extraction 335 
In order to determine whether bacteriophage pre-treatment may influence the ability of P. 336 
aeruginosa S1 68 to initiate stress response mechanisms during SODIS-CPC treatment, 5 mL of 337 
each collected sample was treated with a 1% phenol/19% ethanol (final v/v) mixture, incubated at 4 338 
°C for 45 min and centrifuged at 3 320 × g for 15 min at 4 °C, whereafter the pellet was stored at -339 
80 °C until further analysis (Lambert et al., 2010). Total RNA was extracted from the frozen pellets 340 
using TRI Reagent® (Sigma-Aldrich, St. Louis, Missouri, USA) according to the manufacturer’s 341 
instructions. Following concentration and purity determination of the extracted RNA, using a 342 
NanoDrop® ND-1000 (Nanodrop Technologies Inc., Wilmington, Delaware, USA), 0.2 µg of the 343 
total RNA was DNase treated (Thermo Fisher) and transcribed into cDNA using the Improm-IITM 344 
Reverse Transcription System (Promega) and oligo dT primer as described by the manufacturer. A 345 
no-template control and a no-reverse transcriptase control were included to confirm complete 346 
removal of contaminating genomic DNA from each sample and subsequently included in the 347 
respective qPCR assays. 348 
2.8.3 Absolute and Relative qPCR Assays 349 
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All absolute and relative qPCR assays were conducted using a LightCycler® 96 (Roche 350 
Diagnostics, Risch-Rotkreuz, Switzerland) instrument in combination with the FastStart Essential 351 
DNA Green Master Mix (Roche Diagnostics) (Reyneke et al., 2017). For the absolute quantification 352 
of PAW33 in the collected samples, the Podo-Hypo-F/R primer pair and cycling parameters 353 
outlined in Table 1 were used, while the PS1 5'-ATGAACAACGTTCTGAAATTC-3' and PS2 5'-354 
CTGCGGCTGGCTTTTTCCAG-3' primer pair (Roosa et al., 2014) was used for the absolute 355 
quantification of P. aeruginosa S1 68 with the following cycling parameters: 95 °C (10 min) 356 
followed by 50 cycles of denaturation at 94 °C for 30 s, annealing at 58 °C for 30 s and extension 357 
at 72 °C for 30 s. 358 
For the relative quantification of the rpoS, phzM, recA and lexA genes of P. aeruginosa S1 68 the 359 
primer pairs and cycling parameters as outlined in Table 2 were utilised. The cycle quantification 360 
values (Cq) of the reference gene (rpoS) were utilised to normalise the calculated Cq values of the 361 
target genes (phzM, recA and lexA) amplified from the corresponding samples (ΔCq), and the fold 362 
change (2-ΔΔCq) was compared to the baseline sample (0 h samples) (Dobrowsky et al., 2017). recA 363 
and lexA were selected as target genes as they are involved in the global SOS response initiated 364 
by bacteria upon exposure to adverse environmental conditions, particularly those associated with 365 
DNA damage (inactivation mechanism of SODIS) (Krebs et al., 2018), while phzM is a virulence-366 
associated gene involved in the production of pyocyanin [secondary metabolite (blue-green 367 
pigment) produced by P. aeruginosa] which has also been hypothesised to protect P. aeruginosa 368 
from oxidative stress (inactivation mechanism of SODIS) (Hendiani et al., 2019). High-resolution 369 
melt curve analysis was included for each qPCR assay in order to verify the specificity of the 370 
primer set by ramping the temperature form 65 to 97 °C at a rate of 0.2 °C/s with continuous 371 
fluorescent signal acquisition at 15 readings/°C. Standard curves for the quantification of 372 
P. aeruginosa S1 68 and PAW33 were generated using the methodology outlined in Reyneke et al. 373 
(2017). 374 
3. Results 375 
3.1 Bacteriophage Isolation and Characterisation 376 
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Bacteriophages were selected for further analysis based on the number and consistency of plaque 377 
formation, plaque clarity (clear plaques selected over turbid plaques) and plaque size. 378 
Consequently, bacteriophages PAW33 (isolated using P. aeruginosa ATCC 27853) and PFW25 379 
(isolated using P. fluorescens ATCC 13525) were selected for further analysis. 380 
Based on the STEM micrographs (Fig. 1), both bacteriophages were classified as members of the 381 
order Caudovirales (tailed bacteriophages). The morphological features of PAW33 (Fig. 1 a) 382 
indicated that this bacteriophage belongs to the Podoviridae family. Bacteriophages belonging to 383 
this family are characterised as having short, “stubby” non-contractile tails (Sepúlveda-Robles et 384 
al., 2012). It was observed that the capsid of PAW33 had a hexagonal outline indicating an 385 
icosahedral nature, with the capsid diameter recorded as ~63 nm and the tail measuring < 20 nm 386 
in length (tapering) (Fig. 1). PFW25 was identified as a Myoviridae bacteriophage based on its 387 
morphological features (Fig. 1 b). Bacteriophages belonging to this family are characterised as 388 
having contractile tails (Sepúlveda-Robles et al., 2012). As was observed for PAW33, the capsid of 389 
PFW25 had a hexagonal outline indicating an icosahedral nature; however, the capsid was slightly 390 
elongated. The capsid was ~72 nm wide and ~88 nm long, with the contractile tail measuring 391 
~125 nm (Fig. 1).  392 
3.2 Nucleic Acid Analysis and PCR-based Identification of PAW33 and PFW25 393 
Results obtained following restriction endonuclease digestion with DNaseI (dsDNA), S1 nuclease 394 
(ssDNA) and RNase (RNA) confirmed that the bacteriophages were dsDNA viruses, which 395 
corresponds to their classification in the Caudovirales order. The DNA fragments obtained after 396 
digestion with EcoRI or ClaI indicated that PAW33 had an estimated molecular weight of 73kb, 397 
while the molecular weight of PFW25 could not be estimated following digestion. 398 
Following the design and optimisation of numerous primer sets, the Podo-Hypo-F/R (targeting 399 
Podoviridae) and Myo-Hypo-F/R primer sets (targeting Myoviridae) (Table 1), were selected to 400 
confirm the preliminary classification of the isolated bacteriophages and enable the quantification 401 
of the bacteriophages during the pre-treatment and SODIS-CPC trials. Conventional PCR analysis 402 
of DNA obtained from PAW33 using the Podo-Hypo-F/R primer set resulted in the amplification of 403 
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a 225 bp product. Sequencing analysis of the amplicon indicated that PAW33 shared sequence 404 
similarity with Pseudomonas bacteriophages LP14 (GenBank accession no: MH356729.1), YH30 405 
(GenBank accession no: KP994390.1), phi176 (GenBank accession no: KM411960.1) and Pa2 406 
(GenBank accession no: NC_027345.1), respectively (Appendix A, Table S2). These 407 
bacteriophages are listed as belonging to the Podoviridae family, which further corroborates the 408 
preliminary classification of PAW33. The Podo-Hypo-F/R primer set did not amplify DNA from 409 
PFW25. 410 
Conventional PCR analysis of DNA obtained from PFW25 using the Myo-Hypo-F/R primer set 411 
resulted in the amplification of a 254 bp product. Sequencing analysis of the amplicon indicated 412 
that PFW25 shared sequence similarity with Klebsiella phage vB_Kpn_F48 (GenBank accession 413 
no: MG746602.1) (Appendix A, Table S2). Although the sequence similarity corresponded to a 414 
Klebsiella bacteriophage, vB_Kpn_F48 was classified as a Myoviridae bacteriophage by Ciacci et 415 
al. (2018). This result thus corroborates the preliminary classification of PFW25 as a Myoviridae 416 
bacteriophage. Additionally, the Myo-Hypo-F/R primer set did not amplify DNA from PAW33. 417 
3.3 Host range determination for PAW33 and PFW25 418 
The host range of the isolated bacteriophages was assessed against various target (Pseudomonas 419 
spp.) and non-target bacterial species (Appendix A, Table S1), with activity recorded as the 420 
presence of clear zones or plaques (++), turbid zones or plaques (+) or no growth inhibition (-). 421 
While no activity was observed for PAW33 against the 57 non-target bacterial species analysed, 422 
lytic activity was observed against 92% (n = 11) of the P. aeruginosa strains and 25% (n = 2) of the 423 
other Pseudomonas spp. tested (Fig. 2). In contrast, PFW25 displayed activity against the non-424 
target bacterial species, K. pneumoniae ATCC 10031 and ATCC 333305 (results not shown), but 425 
none of the other non-target bacterial species analysed. PFW25 also displayed lytic activity against 426 
75% (n = 3) of the P. fluorescens strains analysed and against 25% (n = 3) of the other 427 
Pseudomonas spp. tested (Fig. 2). 428 
3.4 Bacteriophage Growth Characteristics and Sensitivity to Physical Parameters 429 
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Under the conditions studied (ambient temperature of 20 to 22 °C and aerobic conditions), PAW33 430 
displayed a latency period of ~80 min, a rise period of ~50 min and a burst size of ~136 PFU per 431 
infected cell, when co-cultured with P. aeruginosa ATCC 27853 (results not shown). As indicated, 432 
K. pneumoniae ATCC 10031 was used to elucidate the life cycle of bacteriophage PFW25 during 433 
the one-step growth experiments and subsequent experiments. Under the conditions studied, 434 
PFW25 displayed a latency and rise period of ~30 min each, while the burst size of PFW25 was 435 
~47 PFU per infected cell (results not shown). 436 
Results from the temperature stability tests indicated that the infectivity of PAW33 remained stable 437 
between 30 °C and 50 °C; however, a significant decrease (~5 log) in infectivity was observed after 438 
10 min at 70 °C and 60 min at 60 °C (Appendix A, Fig. S1 a). A similar temperature sensitivity 439 
profile was observed for PFW25 as its infectivity remained stable between 30 °C and 50 °C. 440 
PFW25 infectivity gradually decreased by ~1 log after 60 min at 60 °C and then remained relatively 441 
constant for the remaining 60 min. In comparison, a significant decrease (~ 4 log) in PFW25 442 
infectivity was recorded after 30 min at 70°C (Appendix A, Fig. S1 b). Results for the pH stability 443 
tests indicated that PAW33 retained infectivity after incubation at pH values ranging from 6.0 to 444 
9.0, while a 0.19 log, 0.41 log and 0.51 log decrease in infectivity was observed following 445 
incubation at pH 4, 5 and 10 (as compared to the mean PFU recorded for pH 6.0 to 9.0) (Appendix 446 
A, Fig. S1 c). In comparison, the infectivity of PFW25 remained relatively constant after incubation 447 
at pH values ranging from 5.0 to 8.0; however, at pH 4.0, 9.0 and 10.0, a 0.43 log, 0.25 log and 448 
0.55 log decrease, in PFW25 infectivity was observed (as compared to the mean PFU recorded for 449 
pH 5.0 to 8.0), respectively (Appendix A, Fig. S1 d). 450 
3.5 Efficiency of PAW33 and PFW25 to Control Target Host Growth 451 
Results for the bacterial challenge tests indicated that the untreated P. aeruginosa control 452 
increased significantly (p = 0.00004) during h 2 to 6 as an increase in sample turbidity was 453 
observed, whereafter bacterial growth started to plateau, remaining relatively constant over the 454 
next 18 h (Appendix A, Fig. S2 a). In comparison, at all three MOI’s analysed, PAW33 was 455 
effectively able to inhibit the proliferation of P. aeruginosa ATCC 27853 during the first 12 h of co-456 
culture, whereafter steady increases in P. aeruginosa growth was observed (Appendix A, 457 
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Fig. S2 a). Although, PAW33 was not able to completely eliminate the P. aeruginosa population, 458 
culture-based analysis following the 24 h co-culture indicated that the P. aeruginosa CFU were 459 
1.30 log (p = 0.0038), 1.08 log (p = 0.0048) and 1.06 log (p = 0.0046) lower in the samples treated 460 
at an MOI of 1, 0.1 and 0.01, respectively, in comparison to the untreated bacterial control (results 461 
not shown). In order to determine whether the increase in P. aeruginosa growth in the PAW33 462 
treated samples was due to the emergence of resistance to the bacteriophage, bacterial cells were 463 
harvested and susceptibility to PAW33 was assessed using the spot-test method. Results 464 
indicated that the P. aeruginosa population were still susceptible to PAW33; however, 465 
bacteriophage resistant mutants had emerged. These colonies were characterised by the 466 
production of a red pigment, which resulted in a red mutant phenotype observed on the TSA plates 467 
(results not shown). Visualisation of these colonies using microscopy and comparison to the 468 
untreated control samples (not treated with PAW33 during co-culture) revealed that these 469 
bacteriophage resistant mutants clumped together following the agglutination test, indicating that 470 
their bacterial cell surface was LPS defective. 471 
Results for the bacterial challenge tests indicated that limited growth was observed in the untreated 472 
K. pneumoniae ATCC 10031 control during the first 4 h, whereafter bacterial growth increased 473 
significantly (p = 0.00003) during the next 6 h and then started to plateau, remaining constant over 474 
the next 12 h (Appendix A, Fig. S2 b). In comparison, PFW25 was effectively able to inhibit the 475 
proliferation of K. pneumoniae during the first 16 h of co-culture for all three MOI ratio’s tested; 476 
however significant increases in K. pneumoniae growth was observed between 16 and 24 h 477 
(Appendix A, Fig. S2 b). Culture-based analysis following the 24 h co-culture indicated that the 478 
K. pneumoniae CFU were 0.94 log (p = 0.0122), 1.05 log (p = 0.0129) and 0.85 log (p = 0.0187) 479 
lower in the samples treated at an MOI of 1, 0.1 and 0.01, respectively, as compared to the 480 
untreated bacterial control (results not shown). Spot test analysis of the culture following 481 
completion of the co-culture experiments indicated that the K. pneumoniae population was still 482 
susceptible to PFW25; however, bacteriophage resistant mutants had also emerged as turbid 483 
plaques (in comparison to clear plaques observed when the untreated K. pneumoniae controls 484 
were subjected to PFW25 during the spot test analysis) were visible. 485 
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3.6 Small-scale Bacteriophage Pre-treatment of Spiked Rainwater Followed by SODIS-CPC 486 
3.6.1 Culture-based and Viability-qPCR Quantification of P. aeruginosa S1 68 and PAW33 487 
The potential of bacteriophages to serve as a biocontrol pre-treatment (8 h and 24 h) of roof-488 
harvested rainwater was investigated using PAW33 and the environmental P. aeruginosa S1 68 489 
strain (Fig. 3). The performance characteristics of the viability-qPCR analysis of P. aeruginosa S1 490 
68 and PAW33 are provided in Appendix A Table S3, while Appendix A Table S4 summarises the 491 
concentration and overall log reduction data for the 8 h and 24 h trials, followed by SODIS-CPC. 492 
For the 8 h trial (Fig. 3 a), culture-based analysis of the non-pre-treated control sample indicated 493 
that the P. aeruginosa S1 68 CFU counts increased by 0.36 log, from 1.38 × 107 CFU/mL to 494 
3.19 × 107 CFU/mL, over the 8 h incubation period. Subsequent exposure of the non-pre-treated 495 
sample to a 4 h SODIS-CPC treatment resulted in a total log reduction of 3.74 (p = 0.0109) in 496 
P. aeruginosa S1 68 CFU counts (2.50 × 103 CFU/mL recorded after SODIS-CPC), from the initial 497 
concentration of 1.38 × 107 CFU/mL (Appendix A, Table S4). Correspondingly, viability-qPCR 498 
analysis indicated that the P. aeruginosa S1 68 GC increased by 0.49 log over the 8 h incubation 499 
period, from 6.13 × 105 GC/mL to 1.88 × 106 GC/mL, with a reduction to 2.80 × 103 GC/mL 500 
recorded following SODIS-CPC treatment [2.33 total log reduction (p = 0.0087)] (Fig. 3 a; Appendix 501 
A, Table S4). Culture-based and viability-qPCR analysis of the corresponding dark control sample 502 
(collected after the 4 h SODIS-CPC treatment), indicated that the concentration of P. aeruginosa 503 
S1 68 remained relatively constant with 2.13 × 107 CFU/mL and 1.81 × 106 GC/mL recorded, 504 
respectively (results not shown). 505 
Culture-based analysis of the corresponding 8 h bacteriophage pre-treated sample indicated that 506 
the P. aeruginosa S1 68 CFU/mL increased by 0.26 log from 1.24 × 107 CFU/mL to 507 
2.28 × 107 CFU/mL, where after the SODIS-CPC treatment reduced the cell counts to 508 
2.58 × 103 CFU/mL [3.68 total log reduction (p = 0.0299) from the initial CFU of 1.24 × 107] (Fig. 509 
3 a; Appendix A, Table S4). Similarly, viability-qPCR analysis indicated that the P. aeruginosa S1 510 
68 gene copies (GC) only increased by 0.19 log during the 8 h pre-treatment, from 511 
6.98 × 105 GC/mL to 1.09 × 106 GC/mL, whereafter the gene copies were reduced to 3.15 × 103 512 
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GC/mL during the SODIS-CPC treatment [2.34 total log reduction (p = 0.0033)] (Appendix A, Table 513 
S4). Monitoring of PAW33 in the 8 h pre-treated sample indicated that the PFU/mL decreased by 514 
0.28 log from 6.00 × 104 PFU/mL to 3.16 × 104 PFU/mL, while 1.20 × 102 PFU/mL were detected 515 
following the SODIS-CPC treatment [2.70 total log reduction (p = 0.0023)] (Appendix A, Fig. S3 a). 516 
In contrast, the PAW33 GC/mL increased by 0.48 log (1.80 × 104 GC/mL to 5.37 × 104 GC/mL) 517 
during the 8 h pre-treatment, whereafter the gene copies remained relatively constant, as 518 
1.42 × 104 GC/mL were recorded following the SODIS-CPC treatment [0.12 total log reduction 519 
(p = 0.1909)] (Appendix A, Table S4 and Fig. S3 a). Culture-based and viability-qPCR analysis of 520 
the corresponding dark control sample (collected after the 4 h SODIS-CPC treatment), indicated 521 
that the concentration of P. aeruginosa S1 68 remained relatively constant with 8.63 × 106 CFU/mL 522 
and 1.23 × 106 GC/mL recorded, respectively, while PAW33 also remained constant as 3.16 × 104 523 
PFU/mL and 1.92 × 104 GC/mL were recorded (results not shown). 524 
For the 24 h trial, culture-based analysis of the non-pre-treated control sample, indicated that 525 
P. aeruginosa S1 68 increased by 0.67 log, from 2.08 × 107 CFU/mL to 9.42 × 107 CFU/mL over 526 
the 24 h incubation period (Fig. 3 b). The P. aeruginosa S1 68 cell counts were subsequently 527 
reduced to 2.5 × 103 CFU/mL (from an initial CFU of 2.08 × 107) following the SODIS-CPC 528 
treatment [3.91 total log reduction (p = 0.0101)] (Appendix A, Table S4). Similarly, viability-qPCR 529 
analysis of the non-pre-treated control sample indicated that the P. aeruginosa S1 68 GC/mL 530 
marginally increased from 2.71 × 106 GC/mL to 3.28 × 106 GC/mL after 24 h (0.08 log increase) 531 
(Fig. 3 b). An overall total reduction of 2.26 log (p = 0.0239) in GC was then observed following the 532 
SODIS-CPC treatment (GC reduced to 1.47 × 104 GC/mL) (Appendix A, Table S4). Culture-based 533 
and viability-qPCR analysis of the corresponding dark control sample (collected after the 4 h 534 
SODIS-CPC treatment), indicated that the concentration of P. aeruginosa S1 68 remained 535 
relatively constant with 9.63 × 107 CFU/mL and 7.98 × 106 PFU/mL recorded, respectively (results 536 
not shown). 537 
Culture-based analysis of the corresponding bacteriophage pre-treated sample from the 24 h trial 538 
indicated that PAW33 was able to restrict the proliferation of P. aeruginosa S1 68 in the pre-treated 539 
sample, as the P. aeruginosa S1 68 CFU counts only increased by 0.14 log, from 2.03 × 107 540 
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CFU/mL to 2.79 × 107 CFU/mL (Fig. 3 b). Subsequent SODIS-CPC treatment of the pre-treated 541 
sample reduced the P. aeruginosa S1 68 CFU counts to 5.0 × 102 CFU/mL [4.61 log reduction 542 
overall (p = 0.0079)], from the initial count of 2.03 × 107 (Appendix A, Table S4). Similarly, viability-543 
qPCR analysis of the pre-treated sample indicated a 0.30 log increase (5.31 × 105 GC/mL to 544 
1.06 × 106 GC/mL) in P. aeruginosa S1 68 GC/mL during the 24 h pre-treatment, whereafter the 545 
GC were reduced to 1.07 × 104 GC/mL due to the SODIS-CPC treatment [2.32 log reduction 546 
overall (p = 0.0128)] (Fig. 3 b; Appendix A, Table S4). Enumeration of the PAW33 plaque counts in 547 
the pre-treated sample indicated that the PFU/mL increased from 8.0 × 104 PFU/mL to 4.0 × 105 548 
PFU/mL (0.70 log increase) during the 24 h pre-treatment, whereafter a decrease to 1.3 × 102 549 
PFU/mL was recorded following the SODIS-CPC treatment [2.79 log reduction overall 550 
(p = 0.0115)] (Appendix A, Fig. S3 b). In comparison, the PAW33 GC/mL remained relatively 551 
constant in the pre-treated sample during the 24 h trial, as 2.50 × 104 GC/mL were detected at both 552 
0 and 24 h, while 4.8 × 103 GC/mL were detected following SODIS-CPC treatment [0.72 log 553 
reduction overall (p = 0.0270)] (Appendix A, Table S4). Culture and viability-qPCR analysis of the 554 
corresponding dark control sample (collected after the 4 h SODIS-CPC treatment), indicated that 555 
the concentration of P. aeruginosa S1 68 remained relatively constant with 4.62 × 107 CFU/mL and 556 
6.45 × 106 GC/mL recorded, respectively, while PAW33 also remained relatively constant as 1.93 × 557 
105 PFU/mL and 2.10 × 104 GC/mL were recorded (results not shown). 558 
3.6.2 Expression of SOS Response- and Virulence-associated Genes of P. aeruginosa S1 68  559 
The performance characteristics of the relative qPCR assays are provided in Appendix A, Table 560 
S3. For the 8 h trial, a similar increase in phzM gene expression was observed for both the pre-561 
treated and non-pre-treated control samples during the 8 h incubation period (Fig 4). While a 562 
decrease in phzM gene expression was observed for both samples following the SODIS-CPC 563 
treatment, the expression level was still up-regulated. In comparison, while an upregulation in recA 564 
gene expression was observed in the non-pre-treated control and pre-treated samples during the 565 
8 h incubation period as well as in the non-pre-treated control sample following the SODIS-CPC 566 
treatment, downregulation of recA was observed for the pre-treated sample following the SODIS-567 
CPC treatment (Fig. 4). lexA was then up-regulated in both the non-pre-treated control and pre-568 
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treated samples during the 8 h incubation period, whereafter downregulation was observed for 569 
both samples during the SODIS-CPC treatment (Fig. 4). Although changes in gene expression 570 
were observed for the collected samples, the fold change in expression was not significant (< 5-571 
fold change) for any of the analysed target genes. 572 
For the 24 h trial, phzM, recA and lexA were up-regulated in the non-pre-treated control sample 573 
during the 24 h incubation period, whereafter downregulation of the phzM and lexA genes were 574 
observed following SODIS treatment (Fig. 4). In comparison, although recA expression in the non-575 
pre-treated control decreased during the SODIS-CPC treatment, the overall level was still up-576 
regulated. Results then indicated that for the PAW33 pre-treated samples, phzM, recA and lexA 577 
were down-regulated during the 24 h trial, with continued downregulation of the genes observed 578 
following the SODIS treatment (Fig. 4). However, similar to the results obtained for the 8 h 579 
incubation trial, the observed fold changes in gene expression were not significant (< 5-fold 580 
change). 581 
4. Discussion 582 
Bacteria are able to undergo an adaptive response and build-up resistance to stressful 583 
environments, such as those experienced during conventional water treatment methods. As 584 
bacteriophages may allow for the selective removal of problematic pathogens within water samples 585 
(Goldman et al., 2009; Turki et al., 2012; Zhang et al., 2013), bacteriophage biocontrol was 586 
investigated and combined with SODIS-CPC in order to reduce the concentration and limit the 587 
proliferation of P. aeruginosa in rainwater. 588 
Lytic bacteriophages displaying activity against Pseudomonas spp. were subsequently isolated 589 
from numerous environmental sources, with PAW33 (isolated using P. aeruginosa) and PFW25 590 
(isolated using P. fluorescens) selected for further characterisation. Electron microscopy and 591 
nucleic acid analysis indicated that both PAW33 and PFW25 belong to the order Caudovirales and 592 
more specifically the Podoviridae and Myoviridae families, respectively. Subsequently, the pH and 593 
temperature sensitivity of PAW33 and PFW25 was assessed as various chemical and physical 594 
parameters (such as those associated with rainwater harvesting systems) may influence the 595 
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viability/infectivity of bacteriophages by damaging their structural elements (e.g. head and tail 596 
structures) (Jończyk et al., 2011). Results however, indicated that both bacteriophages were stable 597 
and retained their infectivity upon exposure to the physico-chemical parameters commonly 598 
associated with untreated harvested rainwater (pH 6.2 to 8.4; 19 to 26 °C) and temperatures 599 
experienced within large-scale SODIS systems (39 to 59 °C) (Reyneke et al., 2018; Strauss et al., 600 
2018). 601 
Caudovirales bacteriophages are associated with more than 140 prokaryotic genera with varying 602 
degrees of host specificity reported (9th International Committee on Taxonomy of Viruses Report, 603 
2011; Kęsik-Szeloch et al., 2013). The host range determination then indicated that PAW33 was 604 
able to infect reference, environmental and clinical isolates of P. aeruginosa, with notable activity 605 
displayed against the multidrug-resistant P. aeruginosa T1 clinical isolate (Havenga et al., 2019) 606 
and numerous environmental strains previously isolated from a solar pasteurization system 607 
connected to a rainwater harvesting tank (Appendix A, Table S1). Additionally, as PAW33 was able 608 
to infect two environmental P. fluorescens strains, it was classified as having a broad host range 609 
against P. aeruginosa strains, with limited activity against other Pseudomonas spp. and no activity 610 
against the non-target bacteria. In comparison, PFW25 was able to infect three P. fluorescens 611 
strains, two environmental and one clinical isolate of P. aeruginosa (Fig. 2) and two K. pneumoniae 612 
ATCC strains (results not shown). The activity displayed against K. pneumoniae and the efficiency 613 
of plating when PFW25 was cultured with K. pneumoniae ATCC 10031, coupled with the sequence 614 
similarity (hypothetical protein targeted by the Myo-Hypo-F/R primer set) displayed to 615 
bacteriophage vB_Kpn_F48, indicated that PFW25 may be better suited to target K. pneumoniae 616 
strains. Similarly, Wu et al. (2007) reported on the isolation of a Myoviridae bacteriophage (Kpp95) 617 
using K. pneumoniae, which was subsequently classified as having a broad host range, as the 618 
bacteriophage displayed lytic activity against K. pneumoniae, K. oxytoca, Enterobacter 619 
agglomerans and Serratia marcescens. 620 
For the bacterial challenge tests, while the bacteriophages PAW33 and PFW25 were able to inhibit 621 
the growth of their respective target hosts (P. aeruginosa ATCC 27853 and K. pneumoniae ATCC 622 
10031), bacteriophage resistant P. aeruginosa and K. pneumoniae mutants had emerged. 623 
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Specifically, for P. aeruginosa ATCC 27853, the bacteriophage resistant mutants were 624 
characterised by the production of a red pigment and were classified as being LPS defective 625 
(based on an agglutination test). A similar observation was made by Le et al. (2014), where it was 626 
demonstrated that a chromosomal DNA deletion (gene fragment containing the hmgA and galU 627 
genes) conferred bacteriophage resistance to P. aeruginosa, with the deletion of hmgA resulting in 628 
the accumulation of a red compound (homogentisic acid) and the deletion of galU resulting in the 629 
loss of the O-antigen (which is required for bacteriophage adsorption). Moreover, as LPS is an 630 
important virulence factor within Gram-negative bacterial pathogens, the authors reported that, in a 631 
mouse infection model, the bacteriophage resistant P. aeruginosa were significantly attenuated (Le 632 
et al., 2014). Thus, while the emergence of bacteriophage resistant bacteria is a major concern 633 
when employing bacteriophage biocontrol, these bacteria (such as the P. aeruginosa obtained in 634 
the current study following exposure to PAW33) may be less virulent (Le et al., 2014) and thereby 635 
pose a lower health risk to the end-user. Bacteriophages do however, have the ability to develop 636 
counter strategies to by-pass bacterial resistance mechanisms and thereby ensure the survival of 637 
the bacteriophage population and in so doing continue to restrict the proliferation of the target 638 
bacterial population (Samson et al., 2013). These strategies include, amongst others, the 639 
modification of the bacteriophage receptor binding proteins, which recognise new 640 
receptors/adsorption sites on bacteria, the production of enzymes to degrade bacterial capsules or 641 
exopolysaccharides, and the modification of the bacteriophage genome to circumvent restriction-642 
modification systems (restriction enzyme digestion) in bacteria (Samson et al., 2013). 643 
The efficiency of bacteriophage biocontrol as a rainwater pre-treatment strategy was ultimately 644 
assessed using PAW33 as the biocontrol agent and P. aeruginosa S1 68 (environmental isolate 645 
obtained from rainwater pasteurized at 70 °C) as the target organism. Based on observations from 646 
the bacterial challenge tests (Appendix A, Fig. S2 a) and a supplementary bacterial challenge test 647 
conducted in sterile rainwater on P. aeruginosa ATCC 27853 and P. aeruginosa S1 68 (results not 648 
shown), two pre-treatment times, namely 8 h and 24 h, were assessed. It was hypothesised that 649 
the bacteriophage pre-treatment would firstly restrict the proliferation of the target host pathogen 650 
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during the pre-treatment period and secondly sensitise the overall bacterial population to the 651 
primary treatment strategy (i.e. SODIS-CPC). 652 
Culture-based and viability-qPCR analysis indicated that PAW33 was able to restrict the 653 
proliferation of the P. aeruginosa S1 68 in the rainwater during both the 8 h and 24 h pre-treatment 654 
trials. However, while similar total CFU and GC log reductions were obtained for the pre-treated 655 
[3.68 log (CFU) and 2.34 log (GC)] and non-pre-treated control samples [3.74 log (CFU) and 2.33 656 
log (GC)] for the 8 h trial (followed by SODIS-CPC); culture-based analysis indicated that a higher 657 
overall log reduction was recorded for the 24 h bacteriophage pre-treated sample followed by 658 
SODIS-CPC (4.61 log) in comparison to the non-pre-treated sample (3.91 log). Additionally, 659 
culture-based analysis indicated that after the 24 h bacteriophage pre-treatment trial, faster 660 
inactivation of P. aeruginosa S1 68 occurred during the first hour (1.73 log reduction) of the 661 
SODIS-CPC treatment. A similar observation was recently reported by Al-Jassim et al. (2018) 662 
where the ability of bacteriophages to sensitise a pathogenic New Delhi metallo β-lactamase-663 
positive E. coli to SODIS was investigated. Results from the study indicated that exposure to 664 
bacteriophages increased the susceptibility of E. coli to SODIS, with faster inactivation of the E. 665 
coli observed (treatment time reduced from 4 h to 2 h). Additionally, using gene expression 666 
analysis, the authors reported that the exposure of E. coli to the bacteriophage resulted in a 667 
downregulation of cell wall functions, the ability to scavenge reactive oxygen species and DNA 668 
repair mechanisms, effectively rendering the E. coli more susceptible to SODIS treatment. It is 669 
however important to note that the Al-Jassim et al. (2018) study utilised a combination of 670 
bacteriophages at a high treatment concentration (MOI = 1), the bacteriophage and SODIS 671 
treatment occurred simultaneously and an artificial light source was used to simulate SODIS. In 672 
contrast, in the current study a lower treatment concentration (MOI = 0.01) of a single 673 
bacteriophage was used as a pre-treatment strategy to SODIS-CPC under natural sunlight. Thus, 674 
while the bacteriophage pre-treatment for 24 h, followed by SODIS-CPC, resulted in the highest 675 
total log reduction (4.61 log) of P. aeruginosa S1 68 CFU/mL, the target host could not be 676 
completely eradicated using this combination treatment strategy, as 5.0 × 102 CFU/mL was still 677 
recorded following SODIS-CPC treatment. Additionally, while viability-qPCR analysis indicated that 678 
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comparable total log reductions [2.32 log (pre-treated) and 2.26 log (non-pre-treated)] in 679 
P. aeruginosa S1 68 concentrations were obtained for the 24 h trial samples, gene copies were still 680 
detected after SODIS-CPC, indicating that viable but non-culturable cells may be present within the 681 
samples. The survival of the P. aeruginosa S1 68 following the combination treatment is however, 682 
not surprising as Pseudomonas spp. may initiate a range of stress responses during both the 683 
planktonic or biofilm life cycles, including the production of heat shock proteins and the initiation of 684 
DNA repair mechanisms, amongst others, and thereby switch to a more tolerant phenotype to 685 
facilitate its survival under adverse conditions (Fux et al., 2005; Breidenstein et al., 2011). 686 
However, as highlighted by Al-Jassim et al. (2018), the ability of bacteria to initiate these stress 687 
response mechanisms may be severely impaired following/during exposure to bacteriophages.  688 
Gene expression analysis was subsequently included to monitor the SOS response-associated 689 
recA and lexA genes, while phzM (gene associated with pyocyanin production) was monitored as 690 
the bacterial challenge tests indicated that decreased pyocyanin was produced by bacteriophage 691 
resistant P. aeruginosa ATCC 27853. Results for the 8 h trial indicated that while recA and lexA 692 
expression levels were decreased in the PAW33 treated sample during the 8 h incubation period 693 
(as compared to the non-pre-treated sample), the overall expression level was still up-regulated, 694 
with downregulation only observed following SODIS-CPC treatment. In comparison, phzM gene 695 
expression was up-regulated in the no treatment control and PAW33 treated samples during the 696 
8 h incubation trial and the subsequent SODIS-CPC treatment. Results for the 24 h trial then 697 
indicated that phzM, recA and lexA were down-regulated in the PAW33 pre-treated sample during 698 
the 24 h incubation period, with continued downregulation observed following the SODIS-CPC 699 
treatment. recA and lexA are known to be up-regulated in bacteria in response to adverse 700 
conditions as part of the SOS response mechanism and are primarily involved in DNA repair 701 
mechanisms (Krebs et al., 2018). The downregulation of recA and lexA in the PAW33 pre-treated 702 
P. aeruginosa S1 68, particularly during the 4 h SODIS-CPC treatment, indicates that the 703 
bacteriophage pre-treatment for both 8 and 24 h may have influenced the ability of the target host 704 
bacterium to initiate stress response mechanisms during the primary treatment strategy (i.e. 705 
SODIS-CPC). However, based on the results obtained, a prolonged bacteriophage pre-treatment 706 
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period may initiate the change in gene expression as recA and lexA were down-regulated during 707 
the 24 h incubation period. Additionally, while assessing the influence of sub-lethal photodynamic 708 
inactivation [sPDI; photo-oxidative stress caused by the generation of reactive oxygen species 709 
(ROS) after a photosensitiser molecule was excited by visible light], Hendiani et al. (2019) reported 710 
that pyocyanin production (phzM expression) in P. aeruginosa ATCC 27853 as well as strains P2 711 
and P3, increased during sPDI, with the authors hypothesising that the over-expression of 712 
pyocyanin played a possible protective role against sPDI-induced oxidative stress. As phzM was 713 
down-regulated in both the 24 h bacteriophage pre-treatment and subsequent SODIS-CPC 714 
samples, in comparison to the observed up-regulation in the 8 h trail samples, it is hypothesised 715 
that the decreased phzM expression may be due to the presence of bacteriophage resistant 716 
P. aeruginosa S1 68 cells within the sample (as was observed for the bacterial challenge tests). 717 
The bacteriophage pre-treatment for 24 h may thus have influenced the ability of the bacteriophage 718 
resistant P. aeruginosa S1 68 cells to initiate pyocyanin production as a stress response 719 
mechanism, rendering the bacterial cells more susceptible to primary disinfection strategies (such 720 
as SODIS-CPC). Additionally, as pyocyanin is considered a virulence factor of P. aeruginosa 721 
(Hendiani et al., 2019), its downregulation in the 24 h PAW33 pre-treated samples indicates that 722 
bacteriophage pre-treatment may decrease pathogen virulence. The overall results thus indicate 723 
that a longer bacteriophage pre-treatment may be required for the bacteriophages to adequately 724 
influence target host stress response mechanisms. 725 
5. Conclusions 726 
Results from the study indicate that PAW33 has the potential to be used in biocontrol strategies for 727 
the selective removal of P. aeruginosa from roof-harvested rainwater as this Podoviridae 728 
bacteriophage was able to effectively restrict the proliferation of P. aeruginosa S1 68 for up to 24 h. 729 
Additionally, an increase in the susceptibility of P. aeruginosa S1 68 to the SODIC-CPC 730 
disinfection treatment was observed after the 24 h bacteriophage pre-treatment trial, as a total log 731 
reduction of 4.61 was recorded. However, while gene copies and CFU were still detected after 732 
SODIS-CPC for both the 8 h and 24 h trials, it important to note that the efficiency of the 733 
bacteriophage pre-treatment may be improved by using a combination of bacteriophages (Gu et 734 
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al., 2016), while the SODIS-CPC treatment efficiency may be further improved by increasing the 735 
SODIS treatment time (6 to 8 h SODIS exposures recommended in literature) (Strauss et al., 736 
2016). 737 
Additionally, although the fold changes observed during gene expression analysis were not 738 
significant, results from the 8 and 24 h bacteriophage pre-treatment trial indicated that the 739 
P. aeruginosa S1 68 exhibited a reduced ability to initiate conventional stress response 740 
mechanisms (recA and lexA), while the expression of pyocyanin (phzM; virulence factor) was also 741 
down-regulated during the 24 h bacteriophage pre-treatment trial. The ability of bacteriophage 742 
biocontrol to influence pathogen stress response mechanisms and virulence during treatment 743 
should thus be further investigated. Moreover, as biofilm formation is a key survival strategy 744 
employed by P. aeruginosa, the biofilm disruption and anti-adhesive abilities of PAW33 should be 745 
investigated in future studies. 746 
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